Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX)
CUSIP: 74006W207
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 28,004,457
- Total 13F shares
- 21,720,756
- Share change
- +2,849,332
- Total reported value
- $1,671,718,000
- Put/Call ratio
- 34%
- Price per share
- $76.96
- Number of holders
- 160
- Value change
- +$223,523,316
- Number of buys
- 87
- Number of sells
- 61
Quarterly Holders Quick Answers
What is CUSIP 74006W207?
CUSIP 74006W207 identifies PRAX - Praxis Precision Medicines, Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74006W207:
Top shareholders of PRAX - Praxis Precision Medicines, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Clarus Lifesciences III, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,894,109
|
$123,282,606 | — | 12 May 2021 | |
| BlackRock, Inc. |
13F
|
Company |
4.7%
|
1,302,435
|
$74,942,110 | — | 30 Sep 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
4.2%
|
1,164,035
|
$66,978,574 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4%
|
1,120,080
|
$64,450,000 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.7%
|
1,038,994
|
$59,783,716 | — | 30 Sep 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
3.7%
|
1,033,244
|
$59,452,860 | — | 30 Sep 2024 | |
| Capital Research Global Investors |
13F
|
Company |
3.6%
|
997,094
|
$57,372,789 | — | 30 Sep 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
3.1%
|
870,000
|
$50,059,800 | — | 30 Sep 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3%
|
854,083
|
$49,143,936 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.8%
|
789,624
|
$45,434,965 | — | 30 Sep 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2.7%
|
761,955
|
$43,842,891 | — | 30 Sep 2024 | |
| VR Adviser, LLC |
13F
|
Company |
2.5%
|
706,131
|
$40,630,778 | — | 30 Sep 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
2%
|
559,151
|
$32,173,549 | — | 30 Sep 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.6%
|
445,233
|
$31,184,119 | — | 30 Sep 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.9%
|
523,566
|
$30,078,867 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
398,838
|
$22,953,599 | — | 30 Sep 2024 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1.3%
|
368,000
|
$21,174,720 | — | 30 Sep 2024 | |
| Velan Capital Investment Management LP |
13F
|
Company |
1.3%
|
350,666
|
$20,177,322 | — | 30 Sep 2024 | |
| 5AM Venture Management, LLC |
13F
|
Company |
1.2%
|
340,000
|
$19,563,600 | — | 30 Sep 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.2%
|
323,105
|
$18,591,462 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.1%
|
304,827
|
$17,539,745 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
279,620
|
$16,089,335 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
0.98%
|
273,895
|
$15,759,918 | — | 30 Sep 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.93%
|
259,398
|
$14,925,761 | — | 30 Sep 2024 | |
| CIBC Asset Management Inc |
13F
|
Company |
0.89%
|
248,939
|
$14,323,950 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.79%
|
219,907
|
$12,653,449 | — | 30 Sep 2024 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.65%
|
183,092
|
$10,535,114 | — | 30 Sep 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.62%
|
174,034
|
$10,013,916 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.61%
|
170,095
|
$9,787,268 | — | 30 Sep 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.59%
|
166,056
|
$9,554,862 | — | 30 Sep 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.58%
|
162,031
|
$9,322,846 | — | 30 Sep 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.54%
|
152,307
|
$8,763,745 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.54%
|
152,267
|
$8,761,443 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.49%
|
137,052
|
$7,885,972 | — | 30 Sep 2024 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.46%
|
130,000
|
$7,480,200 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.38%
|
107,713
|
$6,197,805 | — | 30 Sep 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.3%
|
83,350
|
$4,795,959 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.29%
|
80,500
|
$4,631,970 | — | 30 Sep 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.27%
|
75,187
|
$4,326,260 | — | 30 Sep 2024 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.26%
|
73,185
|
$4,211,065 | — | 30 Sep 2024 | |
| Pale Fire Capital SE |
13F
|
Company |
0.24%
|
67,284
|
$3,871,521 | — | 30 Sep 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
67,045
|
$3,857,769 | — | 30 Sep 2024 | |
| 72 Investment Holdings, LLC |
13F
|
Company |
0.24%
|
65,933
|
$3,793,785 | — | 30 Sep 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.22%
|
60,818
|
$3,499,468 | — | 30 Sep 2024 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.21%
|
57,500
|
$3,308,550 | — | 30 Sep 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.2%
|
55,613
|
$3,199,972 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.18%
|
49,849
|
$2,868,312 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.17%
|
48,207
|
$2,773,831 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.17%
|
48,034
|
$2,763,877 | — | 30 Sep 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.17%
|
46,364
|
$2,667,785 | — | 30 Sep 2024 |
Institutional Holders of Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) as of Q4 2024
As of 31 Dec 2024,
Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) was held by
160 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,720,756 shares.
The largest 10 holders included
Cormorant Asset Management, LP, BlackRock, Inc., PERCEPTIVE ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, MORGAN STANLEY, VANGUARD GROUP INC, Capital Research Global Investors, VR Adviser, LLC, JANUS HENDERSON GROUP PLC, and STATE STREET CORP.
This page lists
160
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
132
Q4 2024 holders
160
Holder diff
28
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.